FDA granted Fast Track Designation to ets-family inhibitor TK216 in Ewing sarcoma patients that have relapsed or are refractory to standard of care therapy. Oncternal Therapeutics Inc., the drug’s sponsor, is in the process of initiating a first-in-human phase I trial in relapsed or refractory Ewing sarcoma. TK216 is a first-in-class small molecule that inhibits […]
FDA approved Epclusa to treat adult patients with chronic hepatitis C virus both with and without cirrhosis. For patients with moderate to severe cirrhosis, Epclusa is approved for use in combination with the drug ribavirin.
STEVEN PAUL was elected chairman of the Foundation for the National Institutes of Health. Paul succeeds Charles Sanders, who has served as chairman since 1997 and will remain a member of the board. In addition, Thomas Insel and Paul Stoffels were elected as new board members. Paul is president and CEO at Voyager Therapeutics, Inc., […]
HAAKON RAGDE was named the 2016 Honorary Member of the American Society for Radiation Oncology, the highest honor ASTRO bestows on members in disciplines other than radiation oncology, radiobiology or radiation physics.
THE WISTAR INSTITUTE has entered into an agreement with the Gene Editing Institute at Christiana Care’s Helen F. Graham Cancer Center & Research Institute, expanding their previous partnership established in 2011. The Gene Editing Institute will be integrated into Wistar’s Molecular Screening Facility. The Gene Editing Institute will retain its management structure and will remain […]
MOUNT SINAI HEALTH SYSTEM and Valley Health System plan to form a partnership that will enable Valley to access Mount Sinai’s roster of clinical trials, as well as develop new programs and services. In December 2015, Valley and Mount Sinai announced plans to collaborate on clinical programs, research and educational offerings. Mount Sinai and Valley […]
IBM Research will undertake research with Melanoma Institute Australia to help further advance the identification of melanoma using cognitive technology. This research builds on IBM’s existing research agreement with MoleMap, which uses advanced visual analytics to analyze more than 40,000 data sets including images and text. IBM Research plans to analyze dermatological images of skin […]
A transcript of Biden’s speech at the National Cancer Moonshot Summit at Howard University.
RESEARCH!AMERICA launched its Campaign for Cures 2016 election blog and an online interactive map featuring hundreds of quotes on medical progress from candidates across the political spectrum running for national office. Managed by former USA Today senior editor and health reporter Janice Lloyd, the blog features election news, survey data, commentary and analysis of presidential […]
FDA granted a fourth Breakthrough Therapy Designation to Imbruvica (ibrutinib) as a potential treatment of chronic graft-versus-host-disease after failure of one or more lines of systemic therapy. The agency also granted the therapy Orphan Drug Designation for the condition. The request was based on preliminary clinical data from a phase Ib/II study evaluating the safety […]
